Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1989 1
1990 1
1991 2
1992 2
1993 2
1994 1
1996 5
1997 2
1998 3
1999 2
2000 1
2001 1
2002 2
2003 3
2004 2
2006 7
2007 7
2008 3
2009 9
2010 11
2011 18
2012 14
2013 21
2014 16
2015 18
2016 20
2017 20
2018 11
2019 16
2020 32
2021 20
2022 23
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

264 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular events and intensity of treatment in polycythemia vera.
Marchioli R, Finazzi G, Specchia G, Cacciola R, Cavazzina R, Cilloni D, De Stefano V, Elli E, Iurlo A, Latagliata R, Lunghi F, Lunghi M, Marfisi RM, Musto P, Masciulli A, Musolino C, Cascavilla N, Quarta G, Randi ML, Rapezzi D, Ruggeri M, Rumi E, Scortechini AR, Santini S, Scarano M, Siragusa S, Spadea A, Tieghi A, Angelucci E, Visani G, Vannucchi AM, Barbui T; CYTO-PV Collaborative Group. Marchioli R, et al. Among authors: musolino c. N Engl J Med. 2013 Jan 3;368(1):22-33. doi: 10.1056/NEJMoa1208500. Epub 2012 Dec 8. N Engl J Med. 2013. PMID: 23216616 Free article. Clinical Trial.
Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial.
Barbui T, Vannucchi AM, De Stefano V, Masciulli A, Carobbio A, Ferrari A, Ghirardi A, Rossi E, Ciceri F, Bonifacio M, Iurlo A, Palandri F, Benevolo G, Pane F, Ricco A, Carli G, Caramella M, Rapezzi D, Musolino C, Siragusa S, Rumi E, Patriarca A, Cascavilla N, Mora B, Cacciola E, Mannarelli C, Loscocco GG, Guglielmelli P, Betti S, Lunghi F, Scaffidi L, Bucelli C, Vianelli N, Bellini M, Finazzi MC, Tognoni G, Rambaldi A. Barbui T, et al. Among authors: musolino c. Lancet Haematol. 2021 Mar;8(3):e175-e184. doi: 10.1016/S2352-3026(20)30373-2. Epub 2021 Jan 18. Lancet Haematol. 2021. PMID: 33476571 Clinical Trial.
Relationship between mitofusin 2 and cancer.
Allegra A, Innao V, Allegra AG, Musolino C. Allegra A, et al. Among authors: musolino c. Adv Protein Chem Struct Biol. 2019;116:209-236. doi: 10.1016/bs.apcsb.2018.11.009. Epub 2018 Dec 27. Adv Protein Chem Struct Biol. 2019. PMID: 31036292 Review.
Role of the microbiota in hematologic malignancies.
Allegra A, Innao V, Allegra AG, Ettari R, Pugliese M, Pulvirenti N, Musolino C. Allegra A, et al. Among authors: musolino c. Neth J Med. 2019 Feb;77(2):67-80. Neth J Med. 2019. PMID: 30895929 Free article. Review.
Immune thrombocytopenia: options and new perspectives.
Caserta S, Zaccuri AM, Innao V, Musolino C, Allegra A. Caserta S, et al. Among authors: musolino c. Blood Coagul Fibrinolysis. 2021 Oct 1;32(7):427-433. doi: 10.1097/MBC.0000000000001058. Blood Coagul Fibrinolysis. 2021. PMID: 34224465 Review.
Mitochondrial DNA is a target of HBV integration.
Giosa D, Lombardo D, Musolino C, Chines V, Raffa G, Casuscelli di Tocco F, D'Aliberti D, Caminiti G, Saitta C, Alibrandi A, Aiese Cigliano R, Romeo O, Navarra G, Raimondo G, Pollicino T. Giosa D, et al. Among authors: musolino c. Commun Biol. 2023 Jul 3;6(1):684. doi: 10.1038/s42003-023-05017-4. Commun Biol. 2023. PMID: 37400627 Free PMC article.
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro.
Rossi M, Vecchi A, Tiezzi C, Barili V, Fisicaro P, Penna A, Montali I, Daffis S, Fletcher SP, Gaggar A, Medley J, Graupe M, Lad L, Loglio A, Soffredini R, Borghi M, Pollicino T, Musolino C, Alfieri A, Brillo F, Laccabue D, Massari M, Boarini C, Abbati G, Pedrazzi G, Missale G, Lampertico P, Ferrari C, Boni C. Rossi M, et al. Among authors: musolino c. Gut. 2023 Nov;72(11):2123-2137. doi: 10.1136/gutjnl-2022-327202. Epub 2023 Jan 30. Gut. 2023. PMID: 36717219 Free PMC article.
Cutaneous adverse reactions to lenalidomide.
Imbesi S, Allegra A, Calapai G, Musolino C, Gangemi S. Imbesi S, et al. Among authors: musolino c. Allergol Immunopathol (Madr). 2015 Jan-Feb;43(1):88-91. doi: 10.1016/j.aller.2013.07.005. Epub 2013 Oct 25. Allergol Immunopathol (Madr). 2015. PMID: 24998775 Review.
The metabolomic signature of hematologic malignancies.
Allegra A, Innao V, Gerace D, Bianco O, Musolino C. Allegra A, et al. Among authors: musolino c. Leuk Res. 2016 Oct;49:22-35. doi: 10.1016/j.leukres.2016.08.002. Epub 2016 Aug 8. Leuk Res. 2016. PMID: 27526405 Review.
Nanobodies and Cancer: Current Status and New Perspectives.
Allegra A, Innao V, Gerace D, Vaddinelli D, Allegra AG, Musolino C. Allegra A, et al. Among authors: musolino c. Cancer Invest. 2018 Apr 21;36(4):221-237. doi: 10.1080/07357907.2018.1458858. Epub 2018 Apr 16. Cancer Invest. 2018. PMID: 29658806 Review.
264 results